Central Asia vs Türkiye: Proportion of the target population who received a 3rd dose of
Central Asia
93.0%
in 2024
Türkiye
95.0%
in 2024
Central Asia rank
1st
Türkiye rank
28th
Proportion of the target population who received a 3rd dose of over time
- Central Asia
- Türkiye
How they compare
Türkiye currently reports 95.0% against 93.0% in Central Asia, a difference of 2.0%.
Across all 13 years both countries report, Türkiye has been ahead every year.
Central Asia ranks 1st and Türkiye ranks 28th of 37 groups.
Türkiye has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central Asia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.8% | 96.9% | 60.1% | Türkiye |
| 2020s | 84.0% | 95.2% | 11.2% | Türkiye |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central Asia or Türkiye?
- Türkiye, at 95.0% against 93.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central Asia and Türkiye?
- 2.0%, with Türkiye ahead.
- How many years of comparable data are there for Central Asia and Türkiye?
- 13 years are reported by both, from 2012 to 2024.
- How do Central Asia and Türkiye rank globally for proportion of the target population who received a 3rd dose of?
- Central Asia ranks 1st and Türkiye ranks 28th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.